Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age

BACKGROUND: Children 6 through 35 months of age are recommended to receive half the dose of influenza vaccine compared with older children and adults. METHODS: This was a 6-site, randomized 2:1, double-blind study comparing full-dose (0.5 mL) trivalent inactivated influenza vaccine (TIV) with half-d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Pediatric Infect Dis Soc
Hauptverfasser: Halasa, Natasha B., Gerber, Michael A., Berry, Andrea A., Anderson, Edwin L., Winokur, Patricia, Keyserling, Harry, Eckard, Allison Ross, Hill, Heather, Wolff, Mark C., McNeal, Monica M., Edwards, Kathryn M., Bernstein, David I.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2015
Schlagworte:
Original Articles and Commentaries
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554205/
https://ncbi.nlm.nih.gov/pubmed/26334249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jpids/piu061
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge